IFNG and neoplasm: By adding the use of monoclonal-depleting antibodies (anti-Gr-1 mAb), our data highlight the significance of MDSC as major tumor-promoting cells, as depletion of MDSC further delayed tumor progression and improved the tumor-specific IFN-γ response.